Detalhe da pesquisa
1.
Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy.
Clin Chem
; 68(10): 1302-1310, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900196
2.
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.
Curr Atheroscler Rep
; 23(11): 72, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515873
3.
A new phenotypic classification system for dyslipidemias based on the standard lipid panel.
Lipids Health Dis
; 20(1): 170, 2021 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838008
4.
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Circulation
; 139(14): 1661-1670, 2019 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630341
5.
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.
Circulation
; 137(23): 2450-2462, 2018 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29526833
6.
Transcatheter aortic valve-in-valve implantation for early failure of sutureless aortic bioprosthesis.
J Card Surg
; 33(4): 172-175, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611217
7.
Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.
Curr Atheroscler Rep
; 19(12): 60, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116404
8.
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study.
Circulation
; 142(15): 1500-1502, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33044856
9.
Emerging Treatments for Heterozygous and Homozygous Familial Hypercholesterolemia.
Rev Cardiovasc Med
; 17(1-2): 16-27, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27667377
10.
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.
Dermatol Clin
; 42(3): 417-428, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38796273
11.
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thromb Haemost
; 124(3): 263-273, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224883
12.
New approaches to triglyceride reduction: Is there any hope left?
Am J Prev Cardiol
; 18: 100648, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584606
13.
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.
J Clin Lipidol
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565461
14.
P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study.
JACC Cardiovasc Interv
; 17(11): 1356-1370, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597172
15.
Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia.
J Clin Med
; 12(4)2023 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835917
16.
JCL Roundtable: From Gen Med to Clinical Lipidology.
J Clin Lipidol
; 17(2): 199-207, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965957
17.
Feasibility of Lipid Screening During First Trimester of Pregnancy to Identify Women at Risk of Severe Dyslipidemia.
J Am Heart Assoc
; 12(10): e028626, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183838
18.
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.
EuroIntervention
; 18(15): 1254-1265, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602868
19.
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.
JACC Cardiovasc Interv
; 16(1): 36-46, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317958
20.
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study.
JACC Cardiovasc Interv
; 16(20): 2528-2539, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609698